However, the upregulated lactyl‐proteins were associated with many physiological and pathological signaling pathways in samples from patients treated with neoadjuvant therapy (Pembrolizumab+Platinum‐based chemotherapy) (Figure S3E and Table S2, Supporting Information), suggesting their potential role in NSCLC treatment. This evidence concerns the gene PROS1 and non-small cell lung carcinoma.